Skip to main content
. 2019 Jan 3;68:58–67. doi: 10.1016/j.intimp.2018.09.043

Table 2.

Effect of ARB treatment on the protection of mice infected intravaginally with HSV-2.

Group Survivors/total Protection index Average survival time (d)
ARB ointment (100 mg/kg/d) 8/10⁎⁎⁎ 71.4% 14.1 ± 1.91
ARB (100 mg/kg/d) 3/10 0% 11.8 ± 2.49
ACV (100 mg/kg/d) 8/10⁎⁎⁎ 71.4% 14.3 ± 1.64
Virus group 3/10# 12.0 ± 2.62
Normal group 10/10 100% >15.0

Note: Drug group compared with virus group: ⁎⁎⁎p < 0.001. Virus group compared with normal group: #p < 0.05.